Drug information for ABLAVAR

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SOLUTION; INTRAVENOUS 2440MG/10ML (244MG/ML) Prescription   GADOFOSVESET TRISODIUM gadofosveset trisodium LANTHEUS MEDCL 21711
2011-12-21 Other Important Information from FDA

2010-12-22 Letter

2010-12-20 Label

2010-01-29 Label

2010-01-15 Letter

2009-04-02 Summary Review

2009-03-31 Review

2009-01-02 Letter
SOLUTION; INTRAVENOUS 3660MG/15ML (244MG/ML) Prescription  (Reference Drug) GADOFOSVESET TRISODIUM gadofosveset trisodium LANTHEUS MEDCL   "

Drug Adverse Effects information for ABLAVAR

Role code Indications Reaction # Reports
PS NUCLEAR MAGNETIC RESONANCE IMAGING NAUSEA 1
PS NUCLEAR MAGNETIC RESONANCE IMAGING SYNCOPE 1
PS NUCLEAR MAGNETIC RESONANCE IMAGING VOMITING 1
PS PRODUCT USED FOR UNKNOWN INDICATION BUDD-CHIARI SYNDROME 1
PS PRODUCT USED FOR UNKNOWN INDICATION NAUSEA 1
PS PRODUCT USED FOR UNKNOWN INDICATION POST PROCEDURAL COMPLICATION 1
PS PRODUCT USED FOR UNKNOWN INDICATION SYNCOPE 1
PS PRODUCT USED FOR UNKNOWN INDICATION VOMITING 1
PS RENAL ANEURYSM NAUSEA 1
PS RENAL ANEURYSM SYNCOPE 1
PS RENAL ANEURYSM VOMITING 1
Ads by Google